SEP 4, 2026 · PHASE 1 TRIAL
A Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid Tumors
ClinicalTrials.gov
Phase 1 trial in early recruitment with no results posted; addresses safety, tolerability, and dose-finding in a novel radiopharmaceutical setting.
Reported
Planned enrollment115
PhasePhase 1–1b
Primary outcome measure (Phase 1)Incidence of Adverse Events by Frequency, D…